Sectoral Asset Management Inc. grew its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) by 235.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 201,000 shares of the company’s stock after purchasing an additional 141,000 shares during the period. Sectoral […]
Sectoral Asset Management Inc. increased its stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) by 235.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 201,000 shares of the company’s stock after purchasing an additional 141,000 shares during the quarter. Sectoral Asset […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Rating) had its price target cut by equities research analysts at Jefferies Financial Group from $120.00 to $70.00 in a research report issued to clients and investors on Friday, The Fly reports. Jefferies Financial Group’s price objective points to a potential upside of 162.27% from the stock’s current price. A […]
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) have been given an average rating of “Buy” by the eleven research firms that are currently covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have updated their coverage on […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) rose 3.6% during trading on Wednesday . The stock traded as high as $18.28 and last traded at $18.12. Approximately 284,046 shares traded hands during trading, a decline of 49% from the average daily volume of 559,839 shares. The stock had previously closed at $17.49. Wall Street Analyst […]